APA Supports Surgeon General Recommendation to Widen Availability of Naloxone

WASHINGTON, D.C. – Today U.S. Surgeon General Jerome Adams, M.D., M.P.H., issued a public health advisory urging more individual Americans to carry a dose of naloxone, a medication that can reverse the effects of an opioid overdose. Death rates from opioid overdoses have been increasing in recent years, and an estimated 2.1 million Americans have opioid use disorder. In response to the surgeon general’s public health advisory, the American Psychiatric Association (APA) issued the following statement from CEO and Medical Director Saul Levin, M.D., M.P.A.:

“Opioid use disorder is a significant public health emergency affecting millions of Americans, as well as their friends and families. We applaud Surgeon General Adams for his public health advisory. There is clear evidence that naloxone can save lives by preventing an opioid overdose. The APA has worked with our psychiatrist members and with other medical organizations to ensure access to treatment for those affected by opioid use disorder, including the use of appropriate medications like naloxone. We hope that by working together with health providers, communities and legislators, we can turn the tide on the opioid epidemic.”

American Psychiatric Association

The American Psychiatric Association, founded in 1844, is the oldest medical association in the country. The APA is also the largest psychiatric association in the world with more than 37,800 physician members specializing in the diagnosis, treatment, prevention and research of mental illnesses. APA’s vision is to ensure access to quality psychiatric diagnosis and treatment. For more information please visit www.psychiatry.org.

Media Contacts

Glenn O'Neal, 202-459-9732
press@psych.org

Erin Connors, 202-609-7113
econnors@psych.org